Media Mentions
| Viewing Latest: 10 | Show: 25 | 50 | All (13) |
05 01 08
AmpliMed Corporation Announces Start of Randomized Phase 2 Trial of Amplimexon in Pancreatic Cancer >>
AmpliMed Corporation, a cancer therapeutics company, today announced that patient enrollment is underway in a Phase 2 trial of Amplimexon® (imexon for injection) in combination with gemcitabine (Gemzar®) in patients with advanced pancreatic cancer. Amplimexon, AmpliMed's lead product candidate, is a chemotherapeutic that has demonstrated clinical and preclinical activity against a range of tumors. The trial is opening at clinical sites throughout the United States.
03 10 08
Kinexis Targets Alzheimer's Through Amyloid Oligomers >>
Since its founding in 2003, Kinexis Inc. has pursued several lead development programs, including prokineticin receptor modulators and melanin concentrating hormone (MCH)-1 receptor antagonists. But the San Diego-based company's third lead program - licensed from the University of California at Irvine in 2004 - turned out to be the charm. The program was built around a platform to generate antibodies targeting oligomeric conformations of amyloid proteins, which form the hallmark plaques of Alzheimer's disease. And in 2006, the amyloid oligomer program officially became Kinexis's primary focus at the urging of new CEO Kevin Anderson.
03 10 08
The roads of wine pass through San Rafael >>
{This article has been translated by Google} SAN RAFAEL. - Towards the south of Mendoza, to 230 kilometers, later to cross the Valley of Uco and San Carlos, he accedes himself to San Rafael, center of a true about 3700 productive oasis of km2 watered by the rivers Diamante and Atuel. The small city counts on airport, casino, hotels of all the categories, spa and a good variety of restaurants, which makes attractive as departure point for the inexhaustible known world of wine.
02 01 08
Thank You For Selling >>
Normally in this space, I like to talk about myself: my recent triumphs, awards, honorary degrees, theoretical breakthroughs in the fields of lifestyle journalism, astrophysics, hydrogen energy, what-have-you, that sort of thing. But this month-only-I'm going to make an exception to talk about an accomplished fellow named Jack Laschever.
01 07 08
Por la ruta de los vinos {By the route of the wines} >>
Little by little the possibility that gains more space in the main vitivinícolas zones of our country people not only visit the warehouses, but that also can be stayed in the place and thus to cross, to taste wines and to learn about this production that has as much presence in our country as in the international markets.
12 11 07
Experimental Leukemia Treatment Boosts Immune System >>
An experimental new leukemia treatment that boosts the body's own immune system to fight disease may prolong life. Early clinical trials show some people who responded to the vaccine experienced event-free survival that was three times longer than those who didn't respond to the leukemia treatment.
12 10 07
Innovative Research Provides Insight Into Improving the Treatment of Several Forms of Leukemia >>
Six studies that highlight important advances in the treatment of leukemia, including acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic-phase chronic myelogenous leukemia (CML), will be presented today at the 49th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, GA.
12 10 07
New Leukemia Vaccine May Prolong Life >>
Patients whose immune system responded to a peptide vaccine for leukemia enjoyed a median remission that was more than three times longer than non-responders, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
12 07 07
Vaccine Improves Event-Free Survival for Leukemia Patients >>
Patients whose immune system responded to a peptide vaccine for leukemia enjoyed a median remission that was more than three times longer than non-responders, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
11 29 07
Strong Pound Creates Bargains in Real Estate >>
The country underwent a severe economic crisis in 2001 and 2002 when many real estate assets halved in price. Many foreign investors snapped up 'distressed assets' which have now returned to their pre-crisis values. While these bargains no longer exist, there are still many opportunities in Argentine real estate, whether in buying apartments in Buenos Aires, holiday homes in Bariloche in Patagonia, vineyards in Mendoza or farmland in the Pampa.